NAD+ Research Protocol: Evidence & Vial Reference

NAD+ is a coenzyme, not a peptide. Both linked research listings state 1000 mg; Peak describes a lyophilised powder, while Pure describes a 10 mL amber vial. The forms are not interchangeable preparation guides.

Research classification: Research summary · not a validated human regimen. The NAD+ 1000 mg vial label reports nominal content; it does not state a suitable amount for human use.

In test subjects, NAD+ functions as an essential coenzyme in redox reactions and as a substrate for sirtuins and PARPs, central to cellular energy metabolism and DNA-repair research models.

Mechanistic findings and early experiments do not by themselves establish clinical efficacy, an approved treatment cycle or equivalence between suppliers' formulations. Interpret claims in the context of the specific experimental model and references.

The earlier catalogue entry described research examples, not a clinically validated schedule for people. The dose, route, frequency or escalation used in one experiment cannot be generalised to a different formulation or to an individual. When primary evidence is not available, do not treat a catalogue number as a recommendation.

For the existing schedule, its evidence caveats and the concentration calculator, see the NAD+ protocol and vial reference. Figures displayed there are research context, not a personalised prescription.

An exact-matching Peak Peptides Australia 1000 mg vial is shown on the research reference page. The product is supplied for in-vitro research, not administration.

Reconstitution cannot be inferred from vial strength alone. Confirm the exact compound, lot, expected appearance, compatible sterile diluent, final volume, transfer method and discard/storage period from validated formulation documentation. BAC water and a 28-day period are not universal defaults. See the illustrated product-specific preparation guide and the abnormal-solution safety guide.

View Peak Peptides Australia's research-only listing and confirm its current labelled strength.

• Rajman L et al. Therapeutic potential of NAD-boosting molecules. Cell Metab. 2018 — Cell Metabolism

For clinical decisions, consult a qualified professional and the product information for an approved formulation. Research-only supplier material must not be injected or used to treat a condition. Explore the A–Z research directory to compare evidence categories.